226 related articles for article (PubMed ID: 24635811)
1. Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
Akar Özkan E; Özdemir BH; Akdur A; Deniz EE; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():136-8. PubMed ID: 24635811
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
Hunt BJ; Thomas JA; Burke M; Walker H; Yacoub M; Crawford DH
Transplantation; 1996 Sep; 62(6):869-72. PubMed ID: 8824493
[TBL] [Abstract][Full Text] [Related]
4. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
5. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder.
Picarsic J; Jaffe R; Mazariegos G; Webber SA; Ellis D; Green MD; Reyes-Múgica M
Cancer; 2011 Oct; 117(19):4540-50. PubMed ID: 21446044
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
[TBL] [Abstract][Full Text] [Related]
7. T-cell acute lymphoblastic leukemia after liver transplant.
Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Ok Atılgan A; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():139-41. PubMed ID: 24635812
[TBL] [Abstract][Full Text] [Related]
8. Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis.
Palazzo JP; Lundquist K; Mitchell D; Mittal KR; Hann HW; Munoz S; Moritz MJ; Jacobs JM; Martin P
Am J Gastroenterol; 1993 Jan; 88(1):102-4. PubMed ID: 8380533
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Posttransplant Lymphoproliferative Disorder in Pediatric Patients With a Liver Transplant.
Aliakbarian M; Dehghani SM; Geramizadeh B; Nikeghbalian S; Kasiri K; Kazemi K; Shamsaeefar A; Bahador A; Malekhosseini SA
Exp Clin Transplant; 2015 Oct; 13(5):426-9. PubMed ID: 25232740
[TBL] [Abstract][Full Text] [Related]
10. Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells.
Wowro SJ; Schmitt KRL; Tong G; Berger F; Schubert S
Int Immunopharmacol; 2016 Jan; 30():9-17. PubMed ID: 26613512
[TBL] [Abstract][Full Text] [Related]
11. Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Watts RG; Hilliard LM; Berkow RL
J Pediatr Hematol Oncol; 2002 Nov; 24(8):622-6. PubMed ID: 12439033
[TBL] [Abstract][Full Text] [Related]
12. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
Roque J; Rios G; Humeres R; Volpi C; Herrera JM; Schultz M; Rios H; Rius M; Salgado C; Hepp J
Transplant Proc; 2006 Apr; 38(3):930-1. PubMed ID: 16647513
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant Lymphoproliferative Disorder Manifesting as Intestinal Epstein-Barr Virus-Positive Anaplastic Large-Cell Lymphoma in an Adult Renal Transplant Recipient.
Börcek P; Özdemir BH; Özgün G; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):64-66. PubMed ID: 27805515
[TBL] [Abstract][Full Text] [Related]
14. Burkitt's lymphoma following a pediatric liver transplantation: predictive negative value of serologic response to Epstein-Barr virus.
Yilmaz A; Hazar V; Akçam M; Inanç-Gürer E; Ceken K; Artan R
Turk J Pediatr; 2007; 49(4):434-6. PubMed ID: 18246749
[TBL] [Abstract][Full Text] [Related]
15. A case report: hepatic posttransplant lymphoproliferative disorder in a non-liver transplant patient.
Koyun M; Hazar V; Akkaya B; Comak E; Gökçeoğlu AU; Doğan CS; Çubuk SM; Akman S
Transplant Proc; 2011 Jun; 43(5):2102-6. PubMed ID: 21693336
[TBL] [Abstract][Full Text] [Related]
16. A Fatal Complication of Liver Transplant: Posttransplant Lymphoproliferative Disease.
Hizarcioglu-Gulsen H; Gumus E; Demir H; Saltik-Temizel IN; Varan A; Dincer HA; Dogrul AB; Ozen H
Exp Clin Transplant; 2022 May; 20(Suppl 3):102-104. PubMed ID: 35570611
[TBL] [Abstract][Full Text] [Related]
17. Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation.
Smets F; Vajro P; Cornu G; Reding R; Otte JB; Sokal E
Transplantation; 2000 Mar; 69(5):982-4. PubMed ID: 10755561
[TBL] [Abstract][Full Text] [Related]
18. [Gingival Burkitt lymphoma in a hepatitis C-positive renal transplant patient].
Unholzer A; Starz H; Hirschsteiner O; Balda BR
J Dtsch Dermatol Ges; 2005 Jan; 3(1):46-51. PubMed ID: 16353750
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-negative precursor B cell lymphoblastic lymphoma after liver transplantation: a unique form of posttransplant lymphoproliferative disease.
Borges E; Ferry JA; Friedmann AM
Transplantation; 2002 Feb; 73(4):541-3. PubMed ID: 11889425
[TBL] [Abstract][Full Text] [Related]
20. Burkitt s lymphoma variant of post-transplant lymphoproliferative disease (PTLD).
Pasquale MA; Weppler D; Smith J; Icardi M; Amador A; Gonzalez M; Kato T; Tzakis A; Ruiz P
Pathol Oncol Res; 2002; 8(2):105-8. PubMed ID: 12172573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
